Fig. 3From: Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factorsChanges in coagulation biomarkers during days 1–5 in the intensive care unit (ICU) for patients with iARDS, dARDS, or pneumonia. PT-INR, prothrombin time–international normalized ratio; FDP, fibrin degradation products; TAT, thrombin–antithrombin complex; PIC, plasmin–α2-plasmin inhibitor complex; PAI-1, plasminogen activator inhibitor-1. Data are expressed as the mean, with the 95% confidence interval shown by the error barsBack to article page